Stock indexes fell again, capping a week in which the Dow Jones Industrial Average posted its steepest decline since December, driven by large share-price swings at widely followed companies issuing quarterly earnings reports.
Shares of biotechnology companies led Friday’s decline, after Biogen plunged 22% on a soft sales outlook.